Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
A Agilent Technologies	$125.63 +0.5%	$118.39	$96.43 ▼ $153.84	$35.50B	1.22	1.39 million shs	1.78 million shs
AMN AMN Healthcare Services	$20.77 +3.6%	$19.88	$14.86 ▼ $54.00	$768.40M	0.1	1.17 million shs	1.06 million shs
MEDP Medpace	$475.51 +0.5%	$395.75	$250.05 ▼ $501.30	$13.29B	1.42	341,743 shs	408,536 shs
TMO Thermo Fisher Scientific	$493.05 +0.7%	$452.50	$385.46 ▼ $627.88	$184.93B	0.74	1.91 million shs	1.23 million shs

7 Stocks to Ride The A.I. Megaboom

We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
A Agilent Technologies	+5.34%	+6.91%	+4.45%	+11.93%	-11.28%
AMN AMN Healthcare Services	-0.50%	+1.88%	+3.63%	-5.00%	-62.22%
MEDP Medpace	-0.11%	+4.32%	+5.59%	+59.53%	+24.13%
TMO Thermo Fisher Scientific	+0.44%	+1.48%	+1.63%	+21.91%	-19.99%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
A Agilent Technologies	4.6027 of 5 stars	2.3	5.0	2.5	3.6	2.8	0.8	2.5
AMN AMN Healthcare Services	4.4444 of 5 stars	3.1	3.0	0.0	4.3	3.1	1.7	1.9
MEDP Medpace	4.3523 of 5 stars	2.0	3.0	0.0	4.6	2.9	4.2	1.9
TMO Thermo Fisher Scientific	4.9472 of 5 stars	3.4	4.0	2.5	4.1	3.0	2.5	2.5

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
A Agilent Technologies	2.50	Moderate Buy	$139.25	10.84% Upside
AMN AMN Healthcare Services	2.25	Hold	$28.25	36.00% Upside
MEDP Medpace	1.93	Reduce	$406.60	-14.49% Downside
TMO Thermo Fisher Scientific	2.73	Moderate Buy	$593.00	20.27% Upside

Current Analyst Ratings Breakdown

Latest TMO, MEDP, A, and AMN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/29/2025	A Agilent Technologies	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Equal Weight ➝ Equal Weight	$125.00
8/28/2025	A Agilent Technologies	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$141.00 ➝ $142.00
8/28/2025	A Agilent Technologies	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$135.00 ➝ $140.00
8/28/2025	A Agilent Technologies	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	In-Line ➝ In-Line	$130.00 ➝ $128.00
8/18/2025	TMO Thermo Fisher Scientific	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform
8/12/2025	AMN AMN Healthcare Services	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Market Outperform ➝ Market Outperform	$33.00 ➝ $22.00
8/11/2025	AMN AMN Healthcare Services	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$27.00 ➝ $22.00
7/29/2025	MEDP Medpace	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Neutral ➝ Sell	$300.00 ➝ $305.00
7/25/2025	MEDP Medpace	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$328.00 ➝ $510.00
7/24/2025	TMO Thermo Fisher Scientific	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
7/24/2025	TMO Thermo Fisher Scientific	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$460.00 ➝ $500.00

(Data available from 8/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
A Agilent Technologies	$6.51B	5.48	$6.28 per share	19.99	$22.42 per share	5.60
AMN AMN Healthcare Services	$2.98B	0.27	$14.23 per share	1.46	$15.85 per share	1.31
MEDP Medpace	$2.11B	6.33	$14.03 per share	33.90	$6.14 per share	77.44
TMO Thermo Fisher Scientific	$42.88B	4.34	$30.23 per share	16.31	$133.67 per share	3.69

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
A Agilent Technologies	$1.29B	$4.26	29.49	20.66	3.80	17.97%	25.51%	12.94%	N/A
AMN AMN Healthcare Services	-$146.98M	-$7.77	N/A	8.58	N/A	-10.75%	11.09%	3.34%	11/6/2025 (Estimated)
MEDP Medpace	$404.39M	$13.45	35.35	34.81	2.98	18.74%	67.66%	21.86%	10/20/2025 (Estimated)
TMO Thermo Fisher Scientific	$6.34B	$17.29	28.52	19.29	2.62	15.24%	16.82%	8.38%	10/22/2025 (Estimated)

Latest TMO, MEDP, A, and AMN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/27/2025	Q3 2025	A Agilent Technologies	$1.37	$1.37	N/A	$1.18	$1.67 billion	$1.74 billion
8/7/2025	Q2 2025	AMN AMN Healthcare Services	$0.17	$0.30	+$0.13	-$3.02	$652.89 million	$658.18 million
7/23/2025	Q2 2025	TMO Thermo Fisher Scientific	$5.22	$5.36	+$0.14	$4.28	$10.68 billion	$10.86 billion
7/21/2025	Q2 2025	MEDP Medpace	$3.00	$3.10	+$0.10	$3.10	$537.70 million	$603.31 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
A Agilent Technologies	$0.99	0.79%	N/A	23.24%	9 Years
AMN AMN Healthcare Services	N/A	N/A	N/A	N/A	N/A
MEDP Medpace	N/A	N/A	N/A	N/A	N/A
TMO Thermo Fisher Scientific	$1.72	0.35%	N/A	9.95%	8 Years

Latest TMO, MEDP, A, and AMN Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/10/2025	TMO Thermo Fisher Scientific	quarterly	$0.43	0.4%	9/15/2025	9/15/2025	10/15/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
A Agilent Technologies	0.53	2.25	1.60
AMN AMN Healthcare Services	1.51	1.00	1.00
MEDP Medpace	N/A	0.43	0.43
TMO Thermo Fisher Scientific	0.65	1.93	1.50

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
A Agilent Technologies	N/A
AMN AMN Healthcare Services	99.23%
MEDP Medpace	77.98%
TMO Thermo Fisher Scientific	89.23%

Insider Ownership

Company	Insider Ownership
A Agilent Technologies	N/A
AMN AMN Healthcare Services	0.93%
MEDP Medpace	20.30%
TMO Thermo Fisher Scientific	0.33%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
A Agilent Technologies	17,900	284.07 million	N/A	Optionable
AMN AMN Healthcare Services	2,968	38.32 million	37.97 million	Optionable
MEDP Medpace	5,900	28.09 million	22.39 million	Optionable
TMO Thermo Fisher Scientific	125,000	377.61 million	376.37 million	Optionable

TMO, MEDP, A, and AMN Headlines

Recent News About These Companies

Thermo Fisher Scientific Inc. $TMO is B. Metzler seel. Sohn & Co. AG's 8th Largest Position

August 29 at 8:10 AM | marketbeat.com

Thermo Fisher Scientific Inc. $TMO Position Lessened by Silvant Capital Management LLC

August 29 at 7:58 AM | marketbeat.com

Thermo Fisher Scientific Inc. $TMO Shares Acquired by Guggenheim Capital LLC

August 29 at 7:58 AM | marketbeat.com

Ieq Capital LLC Acquires 5,798 Shares of Thermo Fisher Scientific Inc. $TMO

August 29 at 7:14 AM | marketbeat.com

Rafferty Asset Management LLC Sells 7,965 Shares of Thermo Fisher Scientific Inc. $TMO

August 29 at 6:24 AM | marketbeat.com

Epoch Investment Partners Inc. Sells 11,816 Shares of Thermo Fisher Scientific Inc. $TMO

August 29 at 6:14 AM | marketbeat.com

Caisse DE Depot ET Placement DU Quebec Has $31.82 Million Holdings in Thermo Fisher Scientific Inc. $TMO

August 29 at 6:05 AM | marketbeat.com

Thermo Fisher Scientific to Participate in J.P. Morgan CEO Call Series on September 5, 2025

August 28 at 9:40 PM | joplinglobe.comJ

Should You Continue to Hold Thermo Fisher Stock in Your Portfolio?

August 28 at 9:50 AM | zacks.com

Thermo Fisher Scientific Secures R&D 100 Awards for Innovations Accelerating the Discovery and Development of Therapies

August 28 at 8:30 AM | businesswire.com

Findlay Park Partners LLP Has $166.11 Million Stock Position in Thermo Fisher Scientific Inc. $TMO

August 28 at 8:10 AM | marketbeat.com

Longview Partners Guernsey LTD Sells 56,619 Shares of Thermo Fisher Scientific Inc. $TMO

August 28 at 7:43 AM | marketbeat.com

J. Stern & Co. LLP Raises Position in Thermo Fisher Scientific Inc. $TMO

August 28 at 7:42 AM | marketbeat.com

Thermo Fisher Scientific Inc. $TMO Shares Sold by Corebridge Financial Inc.

August 27 at 8:38 AM | marketbeat.com

Evergreen Wealth Solutions LLC Has $388,000 Stock Position in Thermo Fisher Scientific Inc. $TMO

August 27 at 8:26 AM | marketbeat.com

Taikang Asset Management Hong Kong Co Ltd Lowers Stock Position in Thermo Fisher Scientific Inc. $TMO

August 27 at 7:54 AM | marketbeat.com

Synovus Financial Corp Sells 825 Shares of Thermo Fisher Scientific Inc. $TMO

August 27 at 7:14 AM | marketbeat.com

Thermo Fisher Scientific (NYSE:TMO) CEO Sells $5,009,600.00 in Stock

August 27 at 6:09 AM | insidertrades.com

Ally Financial Inc. Acquires 1,000 Shares of Thermo Fisher Scientific Inc. $TMO

August 26 at 8:30 AM | marketbeat.com

Thematics Asset Management Purchases 6,963 Shares of Thermo Fisher Scientific Inc. $TMO

August 26 at 8:22 AM | marketbeat.com

Mirova Has $75.36 Million Position in Thermo Fisher Scientific Inc. $TMO

August 26 at 8:21 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

TMO, MEDP, A, and AMN Company Descriptions

Agilent Technologies NYSE:A

$125.63 +0.67 (+0.54%)

Closing price 03:59 PM Eastern

Extended Trading

$125.60 -0.03 (-0.03%)

As of 06:16 PM Eastern

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

AMN Healthcare Services NYSE:AMN

$20.77 +0.72 (+3.60%)

Closing price 03:59 PM Eastern

Extended Trading

$20.50 -0.27 (-1.29%)

As of 07:43 PM Eastern

AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. The Nurse and Allied Solutions segment offers travel nurse staffing, labor disruption staffing, local staffing, international nurse and allied permanent placement, and allied staffing solutions. The Physician and Leadership Solutions segment provides locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. The Technology and Workforce Solutions segment offers language services, vendor management systems, workforce optimization, and outsourced solutions. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists. It offers its services under the brands, including AMN Healthcare, Nursefinders, HealthSource Global Staffing, O'Grady Peyton International, Connetics, Medical Search International, DRW Healthcare Staffing, and B.E. Smith. AMN Healthcare Services, Inc. was founded in 1985 and is headquartered in Dallas, Texas.

Medpace NASDAQ:MEDP

$475.51 +2.57 (+0.54%)

Closing price 04:00 PM Eastern

Extended Trading

$466.30 -9.21 (-1.94%)

As of 04:39 PM Eastern

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

Thermo Fisher Scientific NYSE:TMO

$493.05 +3.31 (+0.68%)

Closing price 03:59 PM Eastern

Extended Trading

$492.40 -0.66 (-0.13%)

As of 06:23 PM Eastern

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time